Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Juvenile myasthenia gravis with prepubertal onset.

A Evoli1, A P Batocchi, E Bartoccioni

  • 1Institute of Neurology, Catholic University, Rome, Italy. a.evoli@vsb.it

Neuromuscular Disorders : NMD
|March 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical characteristics and outcome of patients with autoimmune encephalitis: clues for paraneoplastic aetiology.

European journal of neurology·2020
Same author

Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study.

European journal of neurology·2019
Same author

Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigen.

Journal of neuroimmunology·2016
Same author

Prognostic grading after complete resection for thymic malignancies.

European review for medical and pharmacological sciences·2015
Same author

MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study.

Journal of neuroimmunology·2015
Same author

The detection of neural autoantibodies in patients with antiepileptic-drug-resistant epilepsy predicts response to immunotherapy.

European journal of neurology·2014
Same journal

Severe dilated cardiomyopathy in females with dystrophinopathy : a case series of nine patients.

Neuromuscular disorders : NMD·2026
Same journal

A portrait of facioscapulohumeral muscular dystrophy through history: past milestones and future challenges on the road to understanding and treatment.

Neuromuscular disorders : NMD·2026
Same journal

Systematic review of outcome measures in facioscapulohumeral dystrophy (FSHD): validated, usable, and feasible tools for assessing function, performance, and strength.

Neuromuscular disorders : NMD·2026
Same journal

Longitudinal functional trajectories in Duchenne muscular dystrophy: outcome-specific patterns from a registry-based modelling study.

Neuromuscular disorders : NMD·2026
Same journal

HACD1-related congenital myopathy skeletal muscle MRI findings in a Brazilian cohort.

Neuromuscular disorders : NMD·2026
Same journal

Sensory abnormalities and entrapment neuropathies identified by nerve conduction studies in patients with amyotrophic lateral sclerosis.

Neuromuscular disorders : NMD·2026
See all related articles

Juvenile myasthenia gravis (JMG) with prepubertal onset is rare. Children with JMG may have severe symptoms and lower antibody rates, but often achieve good outcomes with treatment, unlike older patients who may have thymoma.

Area of Science:

  • Neurology
  • Pediatrics
  • Immunology

Background:

  • Juvenile myasthenia gravis (JMG) with prepubertal onset is uncommon.
  • Understanding JMG in young children is crucial for effective management.

Purpose of the Study:

  • To compare clinical characteristics and treatment responses of prepubertal JMG with later-onset JMG.
  • To identify unique features and outcomes in young JMG patients.

Main Methods:

  • Retrospective study of 19 prepubertal JMG patients (onset 1.5-9.2 years).
  • Comparison with 114 JMG patients with onset up to 20 years.
  • Analysis of clinical features, antibody status, and treatment outcomes.

Main Results:

  • Prepubertal JMG showed no sex prevalence or other autoimmune diseases.

Related Experiment Videos

  • Ocular myasthenia was more frequent, but generalized symptoms were severe with respiratory involvement in 8/19.
  • Lower anti-acetylcholine receptor antibody rates and higher seronegativity in generalized prepubertal JMG.
  • Spontaneous remission occurred in 3/6 patients with onset before age five.
  • Thymectomy in prepubertal patients had unclear outcomes due to concurrent immunosuppressive therapy; no thymoma found.
  • Most patients achieved good condition with immunosuppressive therapy, similar to older JMG patients.

    • Conclusions:

    • Prepubertal JMG presents distinct features, including severe generalized symptoms and lower antibody detection rates.
    • While thymoma is absent, spontaneous remission is possible in very young children.
    • Treatment outcomes with immunosuppressive therapy are comparable to older JMG patients, highlighting the importance of medical management.